Work

Phase II Trial of Subcutaneous Interferon Followed by Hybrid Bolus/Continuous Infusion Interleukin-2 in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Biotherapy Research Group (CBRG) 95-09

Year: 2005

Type: article

Source: Journal of Immunotherapy

DOI: 10.1097/01.cji.0000190971.95901.68

Authors: Robert O Dillman, Michael C Wiemann, Fritz Tai, Carol DePriest, Gamini Soori, James J Stark, Khosrow Mahdavi, Curtis K Church

Institutions: Hoag Memorial Hospital Presbyterian, St Vincent Hospital, CHI Health Creighton University Medical Center - Bergan Mercy, Cancer Treatment Centers of America, Middle Tennessee State University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2019027524

FWCI:

Cites:

Cited by:

Related to: 10